These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 33554503)

  • 1. Parallel testing of 241 clinical nasopharyngeal swabs for the detection of SARS-CoV-2 virus on the Cepheid Xpert Xpress SARS-CoV-2 and the Roche cobas SARS-CoV-2 assays.
    Tham JWM; Ng SC; Chai CN; Png S; Tan EJM; Ng LJ; Chua RP; Sani M; Chiang D; Tan KX; Tee NWS; Jureen R; Tan SS; Yan G; Yan B; Lee CK
    Clin Chem Lab Med; 2020 Nov; 59(2):e45-e48. PubMed ID: 33554503
    [No Abstract]   [Full Text] [Related]  

  • 2. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay.
    Khoshchehreh M; Wald-Dickler N; Holtom P; Butler-Wu SM
    J Clin Virol; 2020 Dec; 133():104683. PubMed ID: 33142250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraction-Free Methods for the Detection of SARS-CoV-2 by Reverse Transcription-PCR: a Comparison with the Cepheid Xpert Xpress SARS-CoV-2 Assay across Two Medical Centers.
    Cameron A; Pecora ND; Pettengill MA
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33184055
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.
    Serei VD; Cristelli R; Joho K; Salaru G; Kirn T; Carayannopoulous MO; Uprety P
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115208. PubMed ID: 33545455
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical performance of Roche cobas 6800, Luminex ARIES, MiRXES Fortitude Kit 2.1, Altona RealStar, and Applied Biosystems TaqPath for SARS-CoV-2 detection in nasopharyngeal swabs.
    Lee CK; Tham JWM; Png S; Chai CN; Ng SC; Tan EJM; Ng LJ; Chua RP; Sani M; Seow Y; Yan G; Tang J
    J Med Virol; 2021 Jul; 93(7):4603-4607. PubMed ID: 33719033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
    Moran A; Beavis KG; Matushek SM; Ciaglia C; Francois N; Tesic V; Love N
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303565
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    Chen F; Geng Z; Wang J; Liuchang W; Huang D; Xu Y; Wang Z; Wang L
    J Med Virol; 2021 May; 93(5):2805-2809. PubMed ID: 33107614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva.
    Tsang HF; Leung WMS; Chan LWC; Cho WCS; Wong SCC
    Expert Rev Mol Diagn; 2021 May; 21(5):515-518. PubMed ID: 33906571
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical performance and sample freeze-thaw stability of the cobas®6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens.
    Stohr JJJM; Wennekes M; van der Ent M; Diederen BMW; Kluytmans-van den Bergh MFQ; Bergmans AMC; Kluytmans JAJW; Pas SD
    J Clin Virol; 2020 Dec; 133():104686. PubMed ID: 33221622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Laverack M; Tallmadge RL; Venugopalan R; Cronk B; Zhang X; Rauh R; Saunders A; Nelson WM; Plocharczyk E; Diel DG
    Arch Virol; 2021 Sep; 166(9):2551-2561. PubMed ID: 34259914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of three polymerase chain reaction-based assays for detection of SARS-CoV-2 in different upper respiratory tract specimens.
    Eberly AR; Germer JJ; Boerger AC; Fernholz EC; Binnicker MJ; Yao JD
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115441. PubMed ID: 34186320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type.
    Lephart PR; Bachman MA; LeBar W; McClellan S; Barron K; Schroeder L; Newton DW
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115200. PubMed ID: 32980807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?
    Falasca F; Sciandra I; Di Carlo D; Gentile M; Deales A; Antonelli G; Turriziani O
    J Clin Virol; 2020 Dec; 133():104660. PubMed ID: 33126109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of sample pooling for SARS-CoV-2 RNA detection in nasopharyngeal swabs and salivas on the Roche Cobas 6800.
    McMillen T; Jani K; Babady NE
    J Clin Virol; 2021 May; 138():104790. PubMed ID: 33770658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR.
    Torres I; Albert E; Navarro D
    J Med Virol; 2020 Nov; 92(11):2306-2307. PubMed ID: 32369202
    [No Abstract]   [Full Text] [Related]  

  • 18. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
    Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
    Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined throat/nasal swab sampling for SARS-CoV-2 is equivalent to nasopharyngeal sampling.
    Vlek ALM; Wesselius TS; Achterberg R; Thijsen SFT
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):193-195. PubMed ID: 32666481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.